TG and thyroid gland carcinoma: Given the low survival rate of aggressive thyroid cancer patients and the rather low sensitivity of Tg for detecting thyroid cancer recurrence leave room for the development of molecular tools that are more sensitive, and hopefully equally specific, than Tg.